en

PRODUCT DETAIL

Zometa 4 mg/5 ml infúzny koncentrát

Code 41226
MA number EU/1/01/176/006
Product Form: con inf 10x5 ml/4 mg (liek.inj.plast.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Phoenix Labs Unlimited Company, Ireland
Therapeutic Class: 87 - VARIA I
ATC:
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BA Bisphosphonates
M05BA08 Zoledronic acid
Shelf life: 36
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.03.2001
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 07.04.2021
eu-flag.png sk-flag.png